Real-world super-response to biologics in severe asthma: A French monocentric retrospective cohort study

CONCLUSION: In this real-life study in severe T2-high asthma patients, a lower dose or absence of daily oral corticosteroids and absence of eosinophilic granulomatosis with polyangiitis were the only identifiable predictors of super-response to biologics. Physicians should not wait for maintenance oral corticosteroids to be required before considering the initiation of a biologic in severe asthma.PMID:37897876 | DOI:10.1016/j.resmer.2023.101055

Source: Respiratory Care - October 28, 2023 Category: Respiratory Medicine Authors: Sol ène Valéry St éfanie Habib-Maillard Nicolas Roche Source Type: research